New metabolites of drospirenone obtained in Mucorales fungi cultureQUINTANA, Paula G; ROMERO, Stella M; VAAMONDE, Graciela et al.Journal of molecular catalysis. B, Enzymatic. 2013, Vol 97, pp 110-117, issn 1381-1177, 8 p.Article

La drospirénone, un progestatif à activité antagoniste des minéralocorticoïdes = Drospirenon, a progestogen with anti-mineralocorticoid activityPUGEAT, M.La Lettre du gynécologue. 2004, Num 296, pp 37-40, issn 0759-1594, 4 p.Article

Different oral contraceptives and voice quality : an observational studyAMIR, Ofer; BIRON-SHENTAL, Tal; TZENKER, Osnat et al.Contraception (Stoneham). 2005, Vol 71, Num 5, pp 348-352, issn 0010-7824, 5 p.Article

Oral contraception update: focus on a new progestinJournal of reproductive medicine. Supplement. 2002, Vol 47, Num 11, 38 p.Serial Issue

Laboratory Diagnosis of Primary Aldosteronism, and Drospirenone-Ethinylestradiol TherapyPIZZOLO, Francesca; PAVAN, Chiara; CORROCHER, Roberto et al.American journal of hypertension. 2007, Vol 20, Num 12, pp 1334-1337, issn 0895-7061, 4 p.Article

Recent Innovations in Oral ContraceptionCREMER, Miriam; PHAN-WESTON, Scarlett; JACOBS, Adam et al.Seminars in reproductive medicine. 2010, Vol 28, Num 2, pp 140-146, 7 p.Article

Prospective study on sexual behavior of women using 30 μg ethinylestradiol and 3 mg drospirenone oral contraceptiveCARUSO, Salvatore; AGNELLO, Carmela; INTELISANO, Giorgia et al.Contraception (Stoneham). 2005, Vol 72, Num 1, pp 19-23, issn 0010-7824, 5 p.Article

A randomized study over 13 cycles to assess the influence of oral contraceptives containing ethinylestradiol combined with drospirenone or desogestrel on carbohydrate metabolismGASPARD, U; SCHEEN, A; ENDRIKAT, J et al.Contraception (Stoneham). 2003, Vol 67, Num 6, pp 423-429, issn 0010-7824, 7 p.Article

Effects of an oral contraceptive containing drospirenone on bone turnover and bone mineral densityNAPPI, Carmine; DI SPIEZIO SARDO, Attilio; GRECO, Elena et al.Obstetrics and gynecology (New York. 1953). 2005, Vol 105, Num 1, pp 53-60, issn 0029-7844, 8 p.Article

Bleeding profile of a flexible extended regimen of ethinylestradiol/ drospirenone in US women: an open-label, three-arm, active-controlled, multicenter studyJENSEN, Jeffrey T; GARIE, Sona Grossova; TRUMMER, Dietmar et al.Contraception (Stoneham). 2012, Vol 86, Num 2, pp 110-118, issn 0010-7824, 9 p.Article

Contraceptive efficacy of a combined oral contraceptive containing ethinyloestradiol 20 μg/drospirenone 3 mg administered in a 24/4 regimen: a pooled analysis of four open-label studiesANTTILA, Leena; BACHMANN, Gloria; HERNADI, László et al.European journal of obstetrics, gynecology, and reproductive biology. 2011, Vol 155, Num 2, pp 180-182, issn 0301-2115, 3 p.Article

Parenteral oil-based drospirenone microcrystal suspensions—Evaluation of physicochemical stability and influence of stabilising agentsNIPPE, Stefanie; GENERAL, Sascha.International journal of pharmaceutics (Print). 2011, Vol 416, Num 1, pp 181-188, issn 0378-5173, 8 p.Article

A combined oral contraceptive containing 30 mcg ethinyl estradiol and 3.0 mg drospirenone does not impair endothelium-dependent vasodilationMEENDERING, Jessica R; TORGRIMSON, Britta N; MILLER, Nicole P et al.Contraception (Stoneham). 2010, Vol 82, Num 4, pp 366-372, issn 0010-7824, 7 p.Article

Suppression of ovarian activity with a drospirenone-containing oral contraceptive in a 24/4 regimenKLIPPING, Christine; DUIJKERS, Ingrid; TRUMMER, Dietmar et al.Contraception (Stoneham). 2008, Vol 78, Num 1, pp 16-25, issn 0010-7824, 10 p.Article

The use of an oral contraceptive containing ethinylestradiol and drospirenone in an extended regimen over 126 daysFOIDART, Jean-Michel; SULAK, Patricia J; SCHELLSCHMIDT, Ilka et al.Contraception (Stoneham). 2006, Vol 73, Num 1, pp 34-40, issn 0010-7824, 7 p.Article

A combined oral contraceptive containing drospirenone changes neither endothelial function nor hemodynamic parameters in healthy young women: a prospective clinical trialGIRIBELA, Cassiana R. G; MELO, Nilson R; SILVA, Rita C. G et al.Contraception (Stoneham). 2012, Vol 86, Num 1, pp 35-41, issn 0010-7824, 7 p.Article

Bioequivalence study of an oral contraceptive containing ethinylestradiol/ drospirenone/levomefolate calcium relative to ethinylestradiol/ drospirenone and to levomefolate calcium aloneBLODE, Hartmut; KLIPPING, Christine; RICHARD, Frank et al.Contraception (Stoneham). 2012, Vol 85, Num 2, pp 177-184, issn 0010-7824, 8 p.Article

An open-label randomized comparative study of oral contraceptives between medications containing 3 mg drospirenone/30 μg ethinylestradiol and 150 μg levonogestrel/30 μg ethinylestradiol in Thai womenSUTHIPONGSE, Wichit; TANEEPANICHSKUL, Surasak.Contraception (Stoneham). 2004, Vol 69, Num 1, pp 23-26, issn 0010-7824, 4 p.Article

Efficacy and safety of a low-dose 24-day combined oral contraceptive containing 20 μg ethinylestradiol and 3 mg drospirenoneBACHMANN, Gloria; SULAK, Patricia J; SAMPSON-LANDERS, Carole et al.Contraception (Stoneham). 2004, Vol 70, Num 3, pp 191-198, issn 0010-7824, 8 p.Article

Patientes sous contraceptif hormonal : GYNECOLOGIE CONTRACEPTION: Interactions médicamenteusesLa Revue Prescrire. 2012, Vol 32, Num 350, pp 204-208, issn 0247-7750, 5 p., SUPArticle

Antiadipogenic Effects of the Mineralocorticoid Receptor Antagonist Drospirenone: Potential Implications for the Treatment of Metabolic SyndromeCAPRIO, Massimiliano; ANTELMI, Antonella; CHETRITE, Gérard et al.Endocrinology (Philadelphia). 2011, Vol 152, Num 1, pp 113-125, issn 0013-7227, 13 p.Article

Rate of Pregnancy After Using Drospirenone and Other Progestin-Containing Oral ContraceptivesCRONIN, Maureen; SCHELLSCHMIDT, Ilka; DINGER, Jürgen et al.Obstetrics and gynecology (New York. 1953). 2009, Vol 114, Num 3, pp 616-622, issn 0029-7844, 7 p.Article

Comparative Analysis of the Uterine and Mammary Gland Effects of Drospirenone and Medroxyprogesterone AcetateOTTO, Christiane; FUCHS, Iris; ALTMANN, Helga et al.Endocrinology (Philadelphia). 2008, Vol 149, Num 8, pp 3952-3959, issn 0013-7227, 8 p.Article

Drospirenon: ein neues Gestagen mit antimineralokortikoiden Eigenschaften als Bestandteil eines monophasischen oralen Kontrazeptivums = Drospirenone: A new progestin with antimineralocorticoid properties -as a component of a monophasic oral contraceptiveOELKERS, W.Geburtshilfe und Frauenheilkunde. 2001, Vol 61, Num 11, pp 851-856, issn 0016-5751Article

Effect of an oral contraceptive containing drospirenone on the renin-angiotensin-aldosterone system in healthy female volunteersOELKERS, W; HELMERHORST, F. M; WUTTKE, W et al.Gynecological endocrinology. 2000, Vol 14, Num 3, pp 204-213, issn 0951-3590Article